Home » OncoVista Licenses Cancer Drug Compound From New York Firm
OncoVista Licenses Cancer Drug Compound From New York Firm
OncoVista Inc. has signed an exclusive worldwide agreement to license a cancer drug candidate from OSI Pharmaceuticals Inc. Terms of the licensing agreement were not disclosed.
San Antonio Business Journal
San Antonio Business Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May